Portfolio Holdings Detail for ISIN IE00BD1F4M44

Stock Name / Fund	iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	IUVF(GBX) LSE
ETF Ticker	IUVL(USD) LSE
ETF Ticker	QDVI(EUR) F
ETF Ticker	IUVL.LS(USD) CXE
ETF Ticker	IUVF.L(GBP) LSE
ETF Ticker	IUVL.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-12-02 (Tuesday)	474,620	USD 47,950,859	USD 47,950,859	1,028	USD -275,014	USD 101.03	USD 101.83
2025-12-01 (Monday)	473,592	USD 48,225,873	USD 48,225,873	514	USD -1,366,894	USD 101.83	USD 104.83
2025-11-28 (Friday)	473,078	USD 49,592,767	USD 49,592,767	0	USD 94,616	USD 104.83	USD 104.63
2025-11-27 (Thursday)	473,078	USD 49,498,151	USD 49,498,151	0	USD 0	USD 104.63	USD 104.63
2025-11-26 (Wednesday)	473,078	USD 49,498,151	USD 49,498,151	0	USD -487,270	USD 104.63	USD 105.66
2025-11-25 (Tuesday)	473,078	USD 49,985,421	USD 49,985,421	3,926	USD 2,882,560	USD 105.66	USD 100.4
2025-11-24 (Monday)	469,152	USD 47,102,861	USD 47,102,861	171,985	USD 18,051,815	USD 100.4	USD 97.76
2025-11-21 (Friday)	297,167	USD 29,051,046	USD 29,051,046	-658	USD 766,606	USD 97.76	USD 94.97
2025-11-20 (Thursday)	297,825	USD 28,284,440	USD 28,284,440	0	USD -23,826	USD 94.97	USD 95.05
2025-11-19 (Wednesday)	297,825	USD 28,308,266	USD 28,308,266	-329	USD -442,724	USD 95.05	USD 96.43
2025-11-18 (Tuesday)	298,154	USD 28,750,990	USD 28,750,990	1,645	USD 1,217,164	USD 96.43	USD 92.86
2025-11-17 (Monday)	296,509	USD 27,533,826	USD 27,533,826	4,522	USD 402,394	USD 92.86	USD 92.92

Share Trades of MRK by Blackrock for IE00BD1F4M44

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,028	101.800	100.310	100.459	GBX 103,272	85.27
2025-12-01	BUY	514	105.680	101.710	102.107	GBX 52,483	85.08
2025-11-25	BUY	3,926	105.840	100.705	101.219	GBX 397,384	84.12
2025-11-24	BUY	171,985	102.355	99.120	99.444	GBX 17,102,791	83.92
2025-11-21	SELL	-658	100.270	95.360	95.851	GBX -63,070	83.75 Loss of -7,962 on sale
2025-11-19	SELL	-329	97.140	94.090	94.395	GBX -31,056	83.47 Loss of -3,596 on sale
2025-11-18	BUY	1,645	97.660	92.110	92.665	GBX 152,434	83.30
2025-11-17	BUY	4,522	94.740	92.675	92.882	GBX 420,010	83.18
2025-11-14	BUY	4,199	95.075	91.490	91.849	GBX 385,672	83.05
2025-11-10	BUY	3,553	87.370	85.800	85.957	GBX 305,405	82.63
2025-11-07	BUY	1,615	86.570	85.240	85.373	GBX 137,877	82.58
2025-11-04	BUY	1,288	84.960	82.035	82.328	GBX 106,038	82.49
2025-11-03	BUY	323	86.100	82.340	82.716	GBX 26,717	82.49
2025-10-23	BUY	1,316	88.105	86.910	87.030	GBX 114,531	81.97
2025-10-22	SELL	-1,316	88.790	87.030	87.206	GBX -114,763	81.87 Loss of -7,017 on sale
2025-10-21	SELL	-658	87.670	86.230	86.374	GBX -56,834	81.77 Loss of -3,026 on sale
2025-10-20	BUY	329	87.000	85.030	85.227	GBX 28,040	81.70
2025-10-17	BUY	658	84.890	83.200	83.369	GBX 54,857	81.64
2025-10-16	SELL	-987	85.500	83.600	83.790	GBX -82,701	81.60 Loss of -2,163 on sale
2025-10-15	SELL	-658	84.690	83.610	83.718	GBX -55,086	81.55 Loss of -1,425 on sale
2025-10-03	SELL	-1,944	90.700	88.100	88.360	GBX -171,772	81.34 Loss of -13,638 on sale
2025-10-02	BUY	972	91.000	88.220	88.498	GBX 86,020	81.18
2025-10-01	SELL	-972	90.750	85.190	85.746	GBX -83,345	81.01 Loss of -4,608 on sale
2025-09-30	SELL	-324	84.000	78.400	78.960	GBX -25,583	80.95 Profit of 643 on sale
2025-09-29	SELL	-323	78.800	78.030	78.107	GBX -25,229	81.00 Profit of 933 on sale
2025-09-25	BUY	1,610	79.875	77.600	77.827	GBX 125,302	81.12
2025-09-16	BUY	972			81.090*		81.11
2025-09-10	BUY	972			84.030*		80.94
2025-07-28	SELL	-4,860	84.970	83.870	83.980	GBX -408,143	80.72 Loss of -15,842 on sale
2025-07-21	SELL	-324	80.310	78.950	79.086	GBX -25,624	80.41 Profit of 430 on sale
2025-07-17	SELL	-1,296	82.660	81.340	81.472	GBX -105,588	80.38 Loss of -1,416 on sale
2025-07-16	SELL	-3,240	82.640	81.460	81.578	GBX -264,313	80.31 Loss of -4,099 on sale
2025-07-10	SELL	-3,250	85.000	83.170	83.353	GBX -270,897	79.89 Loss of -11,243 on sale
2025-07-08	SELL	-2,916	82.380	80.350	80.553	GBX -234,893	79.68 Loss of -2,540 on sale
2025-07-07	BUY	5,559	81.540	80.150	80.289	GBX 446,327	79.63
2025-07-03	SELL	-3,900	82.600	80.700	80.890	GBX -315,471	79.51 Loss of -5,370 on sale
2025-06-30	SELL	-1,292	79.390	78.380	78.481	GBX -101,397	79.39 Profit of 1,171 on sale
2025-06-27	BUY	323	79.540	78.140	78.280	GBX 25,284	79.40
2025-06-25	BUY	1,292	80.120	79.160	79.256	GBX 102,399	79.42
2025-06-23	SELL	-644	80.220	78.990	79.113	GBX -50,949	79.31 Profit of 127 on sale
2025-06-18	SELL	-2,907	80.310	77.100	77.421	GBX -225,063	79.33 Profit of 5,564 on sale
2025-06-17	SELL	-966	80.700	78.190	78.441	GBX -75,774	79.43 Profit of 956 on sale
2025-06-13	BUY	322	82.440	81.450	81.549	GBX 26,259	79.01
2025-06-11	BUY	7,264	81.680	79.980	80.150	GBX 582,210	78.42
2025-06-04	BUY	945	79.140	77.330	77.511	GBX 73,248	76.69
2025-06-03	SELL	-315	77.185	75.435	75.610	GBX -23,817	76.25 Profit of 202 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy